Consensus Recommendations for the Clinical Application of Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Depression: (Consensus Statement)
Open accessThe DOI matches its Crossref record; 120 of the 120 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To provide expert recommendations for the safe and effective application of repetitive transcranial magnetic stimulation (rTMS) in the treatment of major depressive disorder (MDD). PARTICIPANTS: Participants included a group of 17 expert clinicians and researchers with expertise in the clinical application of rTMS, representing both the National Network of Depression Centers (NNDC) rTMS Task Group and the American Psychiatric Association Council on Research (APA CoR) Task Force on Novel Biomarkers and Treatments. EVIDENCE: The consensus statement is based on a review of extensive literature from 2 databases (OvidSP MEDLINE and PsycINFO) searched from 1990 through 2016. The search terms included variants of major depressive disorder and transcranial magnetic stimulation. The results were limited to articles written in English that focused on adult populations. Of the approximately 1,500 retrieved studies, a total of 118 publications were included in the consensus statement and were supplemented with expert opinion to achieve consensus recommendations on key issues surrounding the administration of rTMS for MDD in clinical practice settings. CONSENSUS PROCESS: In cases in which the research evidence was equivocal or unclear, a consensus decision on how rTMS should be administered was reached by the authors of this article and is denoted in the article as "expert opinion." CONCLUSIONS: Multiple randomized controlled trials and published literature have supported the safety and efficacy of rTMS antidepressant therapy. These consensus recommendations, developed by the NNDC rTMS Task Group and APA CoR Task Force on Novel Biomarkers and Treatments, provide comprehensive information for the safe and effective clinical application of rTMS in the treatment of MDD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Repetitive transcranial magnetic stimulation (rTMS) is an effective method used in clinical practice for treating patients with MDD. 408”
From Major depressive disorder: hypothesis, mechanism, prevention and treatment (2024) · cites this paper as [408]
In the citing paper
“Most clinical rTMS treatments for MDD occur daily (one rTMS session per day) and are applied using scalp-based targeting of DLPFC. These standard treatments are only modestly effective, even in the general MDD population (17, 24–31).”
In the citing paper
“rTMS of the left side of the dorsolateral prefrontal cortex (DLPFC) at 10 Hz is a well-tolerated, evidence-based treatment for TRD.5”
In the citing paper
“While this intensity is consistent with current recommendations for standard rTMS,5 there is no current consensus on the optimal intensity for TBS and other studies have used lower intensities.12”
Citations
Cites
The PHQ-9: Validity of a brief depression severity measure
Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2001) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.2001.016009606.x · Cited by 44,910
Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Stewart, J. W., Warden, D., Niederehe, G., Thase, M. E., Lavori, P. W., Lebowitz, B. D., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.11.1905 · Cited by 5,643
Rossi, S., Hallett, M., Rossini, P. M., & Pascual-Leone, A. (2009) · Clinical Neurophysiology · doi:10.1016/j.clinph.2009.08.016 · Cited by 5,367
NON-INVASIVE MAGNETIC STIMULATION OF HUMAN MOTOR CORTEX
Barker, A. T., Jalinous, R., & Freeston, I. L. (1985) · The Lancet · doi:10.1016/s0140-6736(85)92413-4 · Cited by 4,460
Rush, A. J., Trivedi, M. H., Ibrahim, H. M., Carmody, T. J., Arnow, B., Klein, D. N., Markowitz, J. C., Ninan, P. T., Kornstein, S., Manber, R., et al. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01866-8 · Cited by 3,829
Wassermann, E. M. (1998) · Electroencephalography and Clinical Neurophysiology/Evoked Potentials Section · doi:10.1016/s0168-5597(97)00096-8 · Cited by 2,293
Lefaucheur, J.-P., André-Obadia, N., Antal, A., Ayache, S. S., Baeken, C., Benninger, D. H., Cantello, R. M., Cincotta, M., de Carvalho, M., De Ridder, D., et al. (2014) · Clinical Neurophysiology · doi:10.1016/j.clinph.2014.05.021 · Cited by 2,119
O’Reardon, J. P., Solvason, H. B., Janicak, P. G., Sampson, S., Isenberg, K. E., Nahas, Z., McDonald, W. M., Avery, D., Fitzgerald, P. B., Loo, C., et al. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.01.018 · Cited by 1,910
Self-citationUsing the International 10-20 EEG System for Positioning of Transcranial Magnetic Stimulation
Herwig, U., Satrapi, P., & Schönfeldt-Lecuona, C. (2003) · Brain Topography · doi:10.1023/b:brat.0000006333.93597.9d · Cited by 1,098
George, M. S., Lisanby, S. H., Avery, D., McDonald, W. M., Durkalski, V., Pavlicova, M., Anderson, B., Nahas, Z., Bulow, P., Zarkowski, P., et al. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.46 · Cited by 1,092 · cited 1×
“…magnetic stimulation device package insert as well as in the US Food and Drug Administration (FDA) 510k application material. b In the study by George et al,10 patients underwent head magnetic resonance imaging with fiducials (vitamin E capsules), which resulted in 33.2% of patients having…”
BackgroundSelf-citation
Cited by
Items 501–600 of 690
Wei, K., Chen, K.-Y., Chen, C., Fan, Y., & Cheng, Y. (2026) · Annals of Physical and Rehabilitation Medicine · doi:10.1016/j.rehab.2026.102107 · Cited by 1
Eren, H. İ., & Takım, U. (2026) · Journal of Affective Disorders · doi:10.1016/j.jad.2026.121805 · Cited by 3
Liu, Q., Zhang, J., Duan, X., Zhang, P., Yang, Y., Yao, G., Jiaerheng, B., Shou, X., He, Y., Han, K., et al. (2026) · Molecular Psychiatry · doi:10.1038/s41380-026-03596-2 · Cited by 2
“Repetitive transcranial magnetic stimulation (rTMS), a non-invasive technique for modulating neural activity [16], has demonstrated clinical ef fi cacy in treating various mental disorders, including FDA-approved applications for depression [17, 18].”
Mittelman, L. E., Kazmi, J. S., Syed, S. A., Vargas, L. O., Duehr, J. E., Jerliu, G., Bassett, J. B., Cater, E., & D’Amico, R. S. (2026) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2026.109435 · Cited by 3
Bakır, Ç. N., Genovese, G., Nakonezny, P. A., Azamet, I., Shekunov, J., Voort, J. L. V., Marjańska, M., & Croarkin, P. E. (2026) · BMC Psychiatry · doi:10.1186/s12888-026-08102-0 · Cited by 1
“Treatment with TMS is thought to exert therapeutic effects via induction of action potentials and neuroplasticity, with frequency-dependent modulation of cortical excitability, low frequency being inhibitory (LTD-like) and high frequency being excitatory (LTP-like) [51, 52].”
Henensal, A., Attali, D., Aubry, J., & Plaze, M. (2026) · Translational Psychiatry · doi:10.1038/s41398-026-03999-3 · Cited by 1
Fan, Y., Zhong, Y., Yu, A., Jiang, X., Zhao, H., Wang, Y., Yao, X., Huang, A., Liu, Y., Pu, J., et al. (2026) · Psychiatry Research · doi:10.1016/j.psychres.2026.117244 · Cited by 2
Cao, Z., Shi, Q., Shi, Z., Yuan, D., & Zeng, S. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2026.1816963 · Cited by 1
“…2021). rTMS has been reported to have therapeutic benefits in various neurological and psychiatric conditions, including cerebrovascular accidents, Parkinson’s, movement disorders, depressive disorders, and psychotic conditions (Mcclintock et al., 2018; Safdar et al., 2023; Deng et al., 2025).”
The Value of Neuroimaging for Treating Depression with Brain Stimulation
Sarrazin, V., & O’Shea, J. (2021) · Springer eBooks · doi:10.1007/978-3-030-76136-3_10 · Cited by 1
Vojvodić, S., Katona, G., & Sarač, M. S. (2021) · Medicinski pregled · doi:10.2298/mpns2104117v · Cited by 3
“This treatment involves delivering repetitive magnetic pulses, so it is called repetitive TMS (rTMS) [21, 22].”
BackgroundLongpré-Poirier, C., Juster, R., Miron, J., Kerr, P., Cipriani, E., Jodoin, V. D., & Lespérance, P. (2022) · Comprehensive Psychoneuroendocrinology · doi:10.1016/j.cpnec.2022.100133 · Cited by 1
“Resting motor threshold (rMT) will be determined according to standard techniques [27].”
MethodRegen, F., & Benkert, O. (2020) · Springer eBooks · doi:10.1007/978-3-662-61753-3_1 · Cited by 2
Eckhardt, A., Abegg, A., Seferovic, G., Ibric, S., & Wolf, J. (2022) · vdf Hochschulverlag AG an der ETH Zürich eBooks · doi:10.3218/4138-5 · Cited by 1
Assessment and Management of Suicidal Risk
Melvin, G. A., Oquendo, M. A., Stanley, B., & Posner, K. (2023) · Springer eBooks · doi:10.1007/978-3-030-42825-9_67-1 · Cited by 1
Theta-Burst Stimulation 3 Times a Day for Treatment-Resistant Depression—A New Protocol: Case Series
Ramos, M. R. F., da Silva, V. A., Cavendish, B. A., de Sousa, J. P., da Fonseca, A. S., Luethi, M. S., & Brunoni, A. R. (2023) · Journal of Ect · doi:10.1097/yct.0000000000000928 · Cited by 1
Cunningham, J. E., Bluhm, R. L., Achtyes, E. D., McCright, A. M., & Cabrera, L. Y. (2023) · Journal of Evaluation in Clinical Practice · doi:10.1111/jep.13948 · Cited by 1
“13 Nuttin et al. discussed the importance of increased care for research involving vulnerable populations.”
BackgroundCognitive dysfunction: An important feature of major depressive disorder
Duan, D.-X., Li, X., Yang, L., Wang, W., & Zhu, H. (2023) · Neurons and Neurological Disorders · doi:10.58489/2836-8851/011 · Cited by 1
Transcranial magnetic stimulation in psychiatric disorders
Jiang, S., Fukuda, A. M., Gonsalves, M. A., Kavanaugh, B. C., & Carpenter, L. L. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-18496-3.00004-5 · Cited by 1
Self-citationShahin, H., Safavi, R., McDeavitt, K., & Livingston, R. (2024) · Psychiatric Annals · doi:10.3928/00485713-20240610-01 · Cited by 1
Saha, C., Dastgheib, Z. A., Lithgow, B. J., & Moussavi, Z. (2024) · Neuroscience Insights · doi:10.1177/26331055241268108 · Cited by 2
Intrator, J., Noto, J., Vallesteros, R. D., Peltier, M., O’Reardon, J. P., & Abbas, M. (2024) · Cureus · doi:10.7759/cureus.72993 · Cited by 3
Self-citationEmerging Non-invasive Brain Stimulations for Schizophrenia
Wang, X., Blumberger, D. M., Ismail, P., & Foll, B. L. (2024) · Royal Society of Chemistry eBooks · doi:10.1039/9781837672059-00156 · Cited by 1
Khadanga, M., Kar, N. R., Sahoo, N., & Tripathy, B. (2024) · Digital Chinese Medicine · doi:10.1016/j.dcmed.2025.01.002 · Cited by 2
Kurashige, H., & Kaneko, J. (2025) · International Conference on Artificial Intelligence in Information and Communication (ICAIIC) · doi:10.1109/icaiic64266.2025.10920751 · Cited by 1
“In fact, methods of intervening in such oscillatory activity using external stimuli such as magnetic or electrical stimulation to treat diseases and enhance brain function have been studied [15]–[17].”
Stimulating the brain: a primer
Opri, E., & Cernera, S. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-24824-5.00007-7 · Cited by 2
Non-invasive brain technologies and their role in clinical applications
Sharma, G., & Chowdhury, S. R. (2025) · Expert Review of Medical Devices · doi:10.1080/17434440.2025.2563614 · Cited by 1
“The FDA has approved high-frequency rTMS for major depressive disorder, and there is evidence that it can be used for certain neurological disease [157–159].”
Dupuis, F., Tousignant‐Laflamme, Y., Marier-Deschênes, P., Fournier, P., Nduwimana, I., Ballot, O., Loisel, L., Pinard, A.-M., Lacombe, L., Langevin, P., et al. (2026) · JMIR Research Protocols · doi:10.2196/78952 · Cited by 1
“…cause of specific LBP (eg, fracture, cancer), (3) any specific rTMS-related exclusion criteria (eg, previous seizure, metal in the head, history of stroke), (4) any confirmed drug or alcohol abuse problem [40], and (5) they cannot understand written French (for self-administrated questionnaires).”
Transcranial magnetic stimulation: an item number is justified
PRIDMORE, S. A. (2018) · The Medical Journal of Australia · doi:10.5694/mja17.00849 · Cited by 1
Bennett, E., Almeida, J., & Carpenter, L. L. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.10.367 · Cited by 1
Self-citationAugmentation of neural activity in peripheral nerve of sheep using 6 kHz subthreshold currents
Hope, J., RaviChandran, N., Vanholsbeeck, F., & McDaid, A. (2020) · Physiological Measurement · doi:10.1088/1361-6579/abc01f · Cited by 1
TPH2: A Key Gene Risk Factor and Potential Therapy Target in Depression
Zhang, X., & Wang, Y. (2021) · E3S Web of Conferences · doi:10.1051/e3sconf/202127103070 · Cited by 1
Mood Induction Can Enhance Cognitive Remediation in Depression
Banerjee, M., & Keshav, K. (2020) · International Journal of Cognition and Behaviour · doi:10.23937/2690-3172/1710008 · Cited by 1
“These include repeated transcranial magnetic stimulation (rTMS) in the dorsal part of the prefrontal cortex [7], and deep brain stimulation (DBS) [8].”
BackgroundBalderston, N. L., Beer, J. C., Seok, D., Makhoul, W., Deng, Z., Girelli, T., Teferi, M., Smyk, N., Jaskir, M., Oathes, D. J., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.12.06.408856 · Cited by 1
Sharifi, F., Mahjouri, M. Y., Palizban, F., & Arzaghi, S. M. (2021) · Research Square · doi:10.21203/rs.3.rs-284311/v1 · Cited by 1
Towards Achieving a Home-based Brain Stimulation System
Mansouri, F. (2019) · TSpace (University of Toronto) · Cited by 1
Effects of non-invasive brain stimulation in dystonia: a systematic review and meta-analysisPreprint
Morrison-Ham, J., Clark, G. M., Ellis, E. G., Cerins, A., Joutsa, J., & Enticott, P. G. (2021) · medRxiv · doi:10.1101/2021.11.02.21265839 · Cited by 1
Aaronson, S. T., & Philip, N. S. (2018) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2018.06.001 · Cited by 1
Zhang, W., Zhou, H., Deng, B., Xie, F., Guo, J., Jiang, H. F., Sim, A., Tang, B., & Wang, D. Q. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4111062 · Cited by 1
Sustained Modulation of Deep Brain Circuits with Focused Ultrasonic WavesPreprint
Webb, T. D., Wilson, M. G., Odéen, H., & Kubanek, J. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4310447 · Cited by 1
Klimkeit, E., Rinehart, N., May, T., Whelan, M., & Bradshaw, J. L. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-99967-0.00082-x · Cited by 1
Tran-Chi, V.-L., Maes, M., Nantachai, G., Hemrungrojn, S., Solmi, M., & Tunvirachaisakul, C. (2023) · medRxiv · doi:10.1101/2023.11.03.23297890 · Cited by 1
Oberman, L. M., Penafiel, A. I., Dieterich, R., Phan, C. T., Chou, Y.-Y., Pham, D. L., Adamson, M. M., Hines, C. E., Rezaee, Z., Deng, Z.-D., et al. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2025.1605157
Self-citationConelea, C. A., Philip, N. S., Yip, A. G., Barnes, J. L., Niedzwiecki, M. J., Greenberg, B. D., Tyrka, A. R., & Carpenter, L. L. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.08.033
“Consistent with the recently published consensus recommendations for application of TMS in clinical practice (McClintock et al., 2017), we believe a comprehensive review of health status and physical examination are critical components for evaluating a patient’s appropriateness for TMS therapy.”
MethodSelf-citationSegrave, R. A., Hendrikse, J. J., & Parkes, L. (2018) · Cambridge University Press eBooks · doi:10.1017/9781108164313.021
Bazazeh, D. (2019) · cIRcle (University of British Columbia) · doi:10.14288/1.0375879
“The NeuroStar TMS Therapy System (Neuronetics, Malvern, Pennsylvania) was the first device approved by the FDA to perform rTMS, and was later followed by several other manufactured devices [28].”
MethodRepetitive transcranial magnetic stimulation for depression – Authors' reply
Blumberger, D. M., Vila‐Rodriguez, F., Thorpe, K. E., Daskalakis, Z. J., & Downar, J. H. (2019) · The Lancet · doi:10.1016/s0140-6736(18)32837-x
Once daily versus twice daily theta-burst stimulation in the treatment of major depression disorder
Mielacher, C., Kiebs, M., Dellert, T., Metzner, A., Högenauer, H., Schultz, J., Lamm, C., & Hurlemann, R. (2019) · L Encéphale · doi:10.1016/j.encep.2019.04.023
Drug and Non-drug Treatment of Tourette Syndrome
Zelnik, N. (2019) · Current Drug Therapy · doi:10.2174/1574885514666191121141923
Hope, J., Chandra, N. R., Vanholsbeeck, F., & McDaid, A. (2019) · arXiv (Cornell University) · doi:10.48550/arxiv.1912.02331
“Neuromodulation therapies provide an alternative treatment modality for several drug-resistant neurological conditions, including Parkinson’s, epilepsy, and depression [1-6].”
BackgroundRepetitive Transcranial Magnetic Stimulation
Bigoni, M., Priano, L., Mauro, A., & Capodaglio, P. (2020) · Springer eBooks · doi:10.1007/978-3-030-32274-8_13 · Cited by 1
Transcranial magnetic stimulation for treatment-resistant depression
Nazar, S. (2020) · Nursing Made Incredibly Easy! · doi:10.1097/01.nme.0000658180.68817.30
Electrical and Magnetic Brain Stimulation to Enhance Post-stroke Recovery
Parsons, M. W., & Marquez, J. L. (2020) · Cambridge University Press eBooks · doi:10.1017/9781316286234.027
Miller, N. E. (2021) · Physician Assistant Clinics · doi:10.1016/j.cpha.2021.02.004
Nichtinvasive Hirnstimulationsverfahren in der Psychiatrie
Schwippel, T., & Plewnia, C. (2021) · PSYCH up2date · doi:10.1055/a-1186-7030
“[3] McClintock SM, Reti IM, Carpenter LL et al.”
BackgroundModirrousta, M., Meek, B. P., & Aoun, M. A. (2021) · Advances in Psychiatry and Behavioral Health · doi:10.1016/j.ypsc.2021.05.002
The Electrophysiological Correlates of Morphological Priming in Language Production
Koester, D., Giesbers, R., & Schiller, N. O. (2007) · Max Planck Digital Library
(2022) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.20107
Nichtinvasive Hirnstimulationsverfahren in der Psychiatrie
Schwippel, T., & Plewnia, C. (2022) · Fortschritte der Neurologie · Psychiatrie · doi:10.1055/a-1680-7075
“Er orientiert sich an den kürzlich veröffentlichen Leitlinien zur therapeutischen Nutzung nichtinvasiver Hirnstimulation [1–3]. magnetische Feld besteht für circa 200-400 μs mit einer magnetischen Flussdichte von bis zu 3 Tesla, der Spulen - strom besitzt eine Stärke von 1000-5000 Ampere und es…”
BackgroundZhang, B., Zeng, S., Tang, C., Su, M., Luo, X., Liang, H., & Yang, L. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4068600
Thomson, A. C. (2021) · Research Publications (Maastricht University) · doi:10.26481/dis.20210521at · Cited by 1
Bibliography: Emerging Therapies in Psychiatry
(2018) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.16305
Neuroscience-Informed Treatments
(2019) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.17101
He, J., Li, S., Wang, Y., Zhao, B., Xiao, X., Hou, X., Fang, J., & Rong, P. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.3999247
Measuring Schumann's Resonance with Portable AntennaPreprint
Ranu, O. H. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4184280
Leggett, K., Hennessy, L. A., McAndrew, M., Price, G. W., & Rodger, J. (2022) · Research Square · doi:10.21203/rs.3.rs-1675887/v1
Neurostimulation and Women’s Health
Zaveri, D., Rettenmier, M., & Carlson, P. (2022) · Advances in Psychiatry and Behavioral Health · doi:10.1016/j.ypsc.2022.03.006
La stimulation magnétique répétée pour le traitement des traumas spinaux
Michel‐Flutot, P., & Vinit, S. (2022) · médecine/sciences · doi:10.1051/medsci/2022108
Merkl-Maßmann, A. (2022) · Elsevier eBooks · doi:10.1016/b978-3-437-23031-8.00027-3
Yajing, W. E. N. G., Yi, W. U., Liu, G., CHENG, H., Hongyu, X. I. E., & Shan, T. I. A. N. (2022) · Rehabilitation Medicine · doi:10.3724/sp.j.1329.2022.03012
Genetics of nonpharmacological treatments of depression
Zanardi, R., Carminati, M., Attanasio, F., Fabbri, C., & Serretti, A. (2022) · Psychiatric Genetics · doi:10.1097/ypg.0000000000000332
Li, G., Lei, L., Yang, C., Liu, Z., & Zhang, K. (2023) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s388774 · Cited by 2
Sheen, J., Miron, J., Voetterl, H., Mansouri, F., Zhou, R., Russell, T., Hyde, M., Fox, L., Daskalakis, Z. J., Griffiths, J. D., et al. (2023) · Journal of Affective Disorders Reports · doi:10.1016/j.jadr.2023.100518
Chapter 2. Psychopharmacology and Neuromodulation
Trestman, R. L., & Kablinger, A. S. (2020) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615375288.lg02
Vlaicu, M. B. ̆., & Vlaicu, A. (2023) · Elsevier eBooks · doi:10.1016/b978-2-294-77862-9.00009-8
Muhammad, I., Laswati, H., Kusumawardani, M. K., Konginan, A., & Fazia (2023) · Surabaya Physical Medicine and Rehabilitation Journal · doi:10.20473/spmrj.v5i2.25367
“safe and effective therapeutic tool for depression cases by various institutions.(11,12) In addition, aerobic exercise is also known”
BackgroundLaufer, J., Olmsted, A. M., Sampair, I., Madore, M. R., Yoon, J. H., Hack, L. M., & Keller, C. J. (2023) · medRxiv · doi:10.1101/2023.09.11.23295376
“Head dimensions were measured to localize the approximate area on the motor cortex controlling the right thumb using the Beam F3 method (Mir-Moghtadaei et al., 2015).”
Hung, K.-C., Cheng, C.-M., Liang, S.-C., Sun, C., Chen, C.-M., Cheng, Y., & Chiu, H. (2023) · doi:10.2196/preprints.53381
Martín-López, J. E., Aguilera-Cobos, L., Rosario-Lozano, M. P., & Blasco‐Amaro, J. A. (2023) · doi:10.52766/vmzo8736
Depression and Bipolar Affective Disorder
Zheng, Z., Zou, K., Huang, J., Bao, T., & Han, J. (2023) · Springer eBooks · doi:10.1007/978-981-99-4538-2_18
The Neuro-cardiac Axis in Arrhythmogenesis: Role and Impact of Autonomic Modulation
Chin, S. H., & Ng, G. A. (2023) · Springer eBooks · doi:10.1007/978-3-031-33588-4_9 · Cited by 3
Slepian, P. M. (2024) · Canadian Journal of Pain · doi:10.1080/24740527.2024.2310806
“17 Patients reported their pain intensity on a visual analogue scale (VAS) before treatment and at the completion of sessions 6, 11, 16, and 21 and after treatment conclusion.”
BackgroundMethodrTMS Shows Efficacy in Improving Negative Symptoms in Early Psychosis: A Systematic ReviewPreprint
Hrabok, M., Hinde, A. K., & Song, W.-Y. (2024) · doi:10.22541/au.170664170.00769024/v1
Chemical and Behavioral Addictions: New Perspectives and Challenges
Baetens, K., Kiefer, F., Schellekens, A., & Dom, G. (2024) · Cambridge University Press eBooks · doi:10.1017/9781009067287.002
Zhang, A., xing, J.-J., Wang, J., Liu, X., Xiang, W., & Liu, J. (2024) · doi:10.2196/preprints.59978
Diverse Advanced Approaches of Transcranial Magnetic Stimulation in Obsessive-Compulsive Disorder
Lan, X.-J., Liu, C., Yang, X.-H., & Zheng, W. (2024) · IntechOpen eBooks · doi:10.5772/intechopen.114261
Chapter 48. Treatment of Depression
Collier, S. J., & Nemeroff, C. B. (2024) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615375523.as48
Repetitive transcranial magnetic stimulation to treat chronic tinnitus: a feasibility study
Sickerdick, M., Uy, J., Serrada, I., & Hordacre, B. G. (2024) · Speech Language and Hearing · doi:10.1080/2050571x.2024.2378613 · Cited by 2
“…pre-frontal cortex (DLPFC) (Hordacre, Comacchio, Williams, & Hillier, 2021; Isenberg et al., 2005; McNamara, Ray, Arthurs, & Boniface, 2001; Schutter, 2009), and as such has received approval from the Food and Drug Administration (FDA) and Medicare (Health, 2021; McClintock et al., 2018).”
InfluentialAssessment and Management of Suicidal Risk
Melvin, G. A., Oquendo, M. A., Stanley, B., & Posner, K. (2024) · Springer eBooks · doi:10.1007/978-3-030-51366-5_67
Jiang, Y., Chen, Y., Wei, L., Liu, F., Zheng, Z., Zhang, Z., Li, Z., Tang, Y., Wang, J., Xie, Q., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.09.28.615621
Transcranial magnetic stimulation (TMS)
Batri, A. J., Joseph, C., Yeh, T.-C., & Santhosh, R. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23557-3.00014-0
Sun, Y., Lei, Y., & Lan, F. (2024) · Journal of Psychopathology and Behavioral Assessment · doi:10.1007/s10862-024-10178-5 · Cited by 1
Ge, L., McInnes, A. N., Widge, A. S., & Parhi, K. K. (2025) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2025.3537757 · Cited by 2
“Transcranial magnetic stimulation (TMS), a noninvasive form of brain stimulation can interfere with cognitive control and has been used to treat MDD over the past decade with some success [1], [2], [3], [4], [5].”
Non-invasive neuromodulation as a novel tool in neurorehabilitation
Quiroga, J. A., López, N. M., Otoya, R. E., Galeno, R., Huetagoyena, C., Caseres, C., Fino, D., Moguilner, S., & Ariza, P. (2025) · Elsevier eBooks · doi:10.1016/b978-0-12-819877-3.00014-7
Rakesh, G., Adams, T. G., Ballard, D. H., McLouth, C. J., & Rush, C. R. (2025) · medRxiv · doi:10.1101/2025.03.24.25324326
Application of Neuromodulation Techniques in Super-Refractory Status Epilepticus
王, 灵. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.1541113 · Cited by 1
MRI-free Virtual Neuronavigation for TMSPreprint
Valter, Y., Truong, D. Q., Kawasumi, Y., Bikson, M., & Datta, A. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.04.10.648190
Kimura, J., & Strakowski, J. A. (2025) · Oxford University Press eBooks · doi:10.1093/med/9780197658017.003.0020
Bellini, H., & Brunoni, A. R. (2025) · Springer eBooks · doi:10.1007/978-3-031-85519-1_39
Metadata
- Authors
- McClintock, S. M., Reti, I. M., Carpenter, L. L., McDonald, W. M., Dubin, M., Taylor, S. F., Cook, I. A., O’Reardon, J., Husain, M. M., Wall, C., Krystal, A. D., Sampson, S. M., Morales, O., Nelson, B. G., Latoussakis, V., George, M. S., Lisanby, S. H., & on behalf of both the National Network of Depression Centers rTMS Task Group and the American Psychiatric Association Council on Research Task Force on Novel Biomarkers and Treatments
- Affiliations
- Duke University (US)
- Johns Hopkins University (US)
- Butler Hospital (US)
- Emory University (US)
- Weill Cornell Medicine (US)
- University of Michigan (US)
- University of California, Los Angeles (US)
- American Psychiatric Association (US)
- Mayo Clinic (US)
- Harvard University (US)
- University of Minnesota (US)
- Medical University of South Carolina (US)
- Corresponding author
- McClintock, Shawn M.
- ORCID
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2018-02-21
- Volume
- 79
- Issue
- 1
- Pages
- 35-48
- ISSN
- 0160-6689 (ISSN-L)
- PMC
- PMC5846193
- OpenAlex
- W2617605873
- Cited by
- 693
- References
- 120
- Citations by year
- 2026: 77 · 2025: 94 · 2024: 108 · 2023: 82 · 2022: 85 · 2021: 98 · 2020: 66 · 2019: 54 · 2018: 22
- FWCI
- 20.18
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Institutes of Health (UL1TR002384)
- National Institute of Mental Health (K23MH087739)
- National Center for Advancing Translational Sciences
- Topics
- Life Sciences › Neuroscience › Neurology › Transcranial Magnetic Stimulation Studies
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
- Keywords
- repetitive transcranial magnetic stimulation, major depressive disorder, depression treatment, expert consensus recommendations, antidepressant treatment
- MeSH terms
- Contraindications, Major Depressive Disorder, Humans, Transcranial Magnetic Stimulation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.